Tree Display

AceDB Schema

XML Display


LongText Report for: Bomser_2002_Toxicol.Appl.Pharmacol_178_29

Name Class
Chlorpyrifos oxon CPO activates extracellular signal-regulated kinase ERK 44/42 in Chinese hamster ovary CHOK1 cells but the mechanism is not defined This study tests the hypothesis that diacylglycerol DAG is the secondary messenger responsible for CPO-induced ERK 44/42 activation It is known that DAG is sequentially hydrolyzed by DAG lipase and monoacylglycerol MAG lipase both of which are organophosphate sensitive Inhibition of these enzymes might therefore lead to the accumulation of DAG and MAG of which only DAG is a secondary messenger The experiments show that treatment of CHOK1 cells with CPO significantly inhibits DAG/MAG lipase activity and elevates cellular DAG levels Pretreatment of CHOK1 cells with CPO or a carbamate known to be a DAG lipase inhibitor followed by treatment with a cell-permeable DAG 1,2-dihexanoyl-sn-glycerol results in synergistic activation of ERK 44/42 CPO-potentiated DAG-induced ERK 44/42 activation is both time and concentration dependent This activation is blocked by inhibitors of protein kinase C and mitogen-activated protein kinase kinase suggesting that these enzymes are important in CPO/DAG cellular signaling Activation by a stable DAG analogue phorbol ester was not altered by CPO suggesting that DAG metabolism is the probable target for CPO-potentiated DAG-induced ERK 44/42 activation These observations support the hypothesis that CPO potentiates DAG signaling in CHOK1 cells by inhibiting a CPO-sensitive DAG lipase thereby providing a potential mechanism of toxicity not associated with acetylcholinesterase inhibition 

Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer